# Page 1
Administrative approval for the procurement of medicines and medicinal materials under the State Blood Bank for the implementation of the approved project plan for 2021-22.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: NHM-1222/ PR No. 09/ Health-7
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
The date is March 22, 2022.
(1) Letter from Joint Director (Technical), National Health Mission, Mumbai No: RASO/ Administrative Sanction/ State Blood Cell/ 115932/2022, dated: 21.02.2022.
(ii) Project Implementation Plan approved by the Central Government for the year 2021-2022.
(3) Note approved by the Commissioner Health Services and Mission Director, National Health Mission, Mumbai dated: 11.02.2022.
(4) Government Resolution, Public Health Department No: 2016/ 240/ Health-8, dated: 26.07.2017.
Preamble: The Joint Director (Technical), National Health Mission, Mumbai has informed under Reference Letter No. (1) that in the Project Implementation Plans approved by the Central Government for the year 2021-22, grants are available for the purchase of equipment, materials, kits and medicines required for effective management and achievement of targets of the Hematology, Sickle Cell and Blood Storage Centres (BSUCs) under State Blood Cells. Further, for this purpose, administrative approval has been sought at the Government level for procurement of (a) Rs. 70.90 lakh under FMR Code" 6.1.1.9.1," (b) Rs. 993.30 lakh under FMR Code" 6.2.7.1" and (c) Rs. 3249.67 lakh (Rs. 200.00 lakh+ Rs. 300.00 lakh+ Rs. 2749.67 lakh 3249.67 lakh) under FMR Code" 6.2.7.2."
The proposal has been approved by the Commissioner Health Services and Mission Director, National Health Mission, Mumbai in terms of note no. Therefore, in the Project Implementation Plans approved by the Central Government for the year 2021-22 under the said FMR Code, the Government was considering to grant administrative approval for the purchase of equipment, materials, kits and medicines required for effective regulation and achievement of the target of Hematology, Sickle Cell and Blood Storage Centers (BSUC) under State Blood Cells.
# Page 2
Government Resolution No: PRASHAMA-1222/ PR No. 09/ HEALTH-7
Government's decision:
State in the implementation plans approved by the Central Government for 2021-22
Effective implementation of Hematology, Sickle Cell and Blood Storage Centre (BSUC) under Blood Cell and
FMR for procurement of equipment, materials, kits and medicines required for meeting the target
Rs. 70.90 lakhs (Rupees Seventy Lakhs, Ninety Nine Lakhs) out of the grant sanctioned under the head Code" 6.1.1.9.1"
Administrative approval is granted for the purchase of material goods for an amount of only Rs.
It is:
(A) Equipment for Blood Banks/BSU/BCSU up-gradation of the blood banks for components for Superspeciality hospital Nashik and Gadchiroli..
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| National Health Mission Maharashtra State Approved ROP 2021-22 |
| Sr. No.                                                        | FMR Code  | Particulars                      | Quantity | Cost per Unit (Inclusive of All Taxes) in Rs. | Approved Budget ( Rs. In Lakhs) |
| Up-gradation of the blood banks                                |
| 1                                                              | 6.1.1.9.1 | Refrigertated centrifuge         | 2        | 18,00,000/                                    | 36.00                           |
| 2                                                              | 6.1.1.9.1 | Luminal Air Flow                 | 2        | 1,50,000/                                     | 3.00                            |
| 3                                                              | 6.1.1.9.1 | Plasma Expresser                 | 4        | 30,000/                                       | 1.20                            |
| 4                                                              | 6.1.1.9.1 | 2-8° C Refrigerator 600 Ltrs     | 2        | 4,50,000/                                     | 9.00                            |
| 5                                                              | 6.1.1.9.1 | - 40° C Freezer 600 Ltrs         | 2        | 4,10,000/                                     | 8.20                            |
| 6                                                              | 6.1.1.9.1 | Platelet agitator With Incubator | 2        | 1,20,000/                                     | 2.40                            |
| 7                                                              | 6.1.1.9.1 | Thawing Bath                     | 2        | 1,50,000/                                     | 3.00                            |
| 8                                                              | 6.1.1.9.1 | Incubator                        | 2        | 50,000/                                       | 1.00                            |
| 9                                                              | 6.1.1.9.1 | 3 parts cell counter             | 2        | 3,50,000/                                     | 7.00                            |
| 10                                                             | 6.1.1.9.1 | Weighing Machine/Scale           | 2        | 5,000/                                        | 0.10                            |
| Total (A)...                                                   | 70.90     |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Sickle Cell Disease under State Blood Cell as per approved PIP 2021-22
An amount of Rs. 1977.30 lakh has been sanctioned under the head FMR Code" 6.2.7.1" for control
Administrative Sanction for procurement of medicines amounting to Rs. 993.30 lakh from subsidy as under:
It is provided:
(B)
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| National Health Mission Maharashtra State Approved ROP 2021-22 |
| Sr. No.                                                        | FMR Code | Particulars                                           | Quantity    | Cost per Unit (Inclusive GST) in Rs. | Approved Budget (Rs. In Lakhs) |
| 1                                                              | 6.2.7.1  | Cap. Hydroxyurea 500mg                                | 10,95,000   | 4/                                   | 43.80                          |
| 2                                                              | 6.2.7.1  | Tablet Folic Acid 5mg                                 | 1,09,50,000 | 1/                                   | 109.50                         |
| 3                                                              | 6.2.7.1  | Leucodepletion bed side filters for blood transfusion | 1,20,000    | 700/                                 | 840.00                         |
| Total (B)...                                                   | 993.30   |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Page 2 of 6
# Page 3
Government Resolution No: PRASHAMA-1222/ PR No. 09/ HEALTH-7
Haemophilia and Thalassemia under Blood Cell Programme as per approved PIP 2021-22
Under the meaning of FMR Code" 6.2.7.2" for the purchase of medicines required for the treatment of patients
A grant of Rs. 3850.00 lakh has been received. Grants received for this purpose
Purchase of drugs and pharmaceuticals amounting to Rs. 3249.67 lakh is administered as follows:
It is approved:
(C)
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| National Health Mission Maharashtra State Approved ROP 2021-22 |
| THALASSEMIA                                                    |
| Sr. No.                                                        | FMR Code | Medicine Name          | Strengnth               | Total     |  Quantity | Proposed approx. Unit Rate Including all Taxes (In Rs.) | Total Rs.in Lakhs |
| 1                                                              | 6.2.7.2  | Tab. Deferasinox       | 250mg                   | 11,92,857 | 5.60      | 66.80                                                   |
| 2                                                              | 6.2.7.2  | Tab. Deferasinox       | 500mg                   | 9,94,047  | 10.08     | 100.20                                                  |
| 3                                                              | 6.2.7.2  | Tab. Deferasinox       | 250mg                   | 1,69,724  | 4.36      | 7.40                                                    |
| 4                                                              | 6.2.7.2  | Tab. Deferasinox       | 500mg                   | 1,45,669  | 7.62      | 11.10                                                   |
| 5                                                              | 6.2.7.2  | Inj. Desferal          | 500mg_                  | 3,000     | 1.50      | 4.50                                                    |
| 6                                                              | 6.2.7.2  | FCT Deferasinox        | 180mg                   | 50,000    | 20.00     | 10.00                                                   |
| Sub Total (I)..                                                | 200.00   |
| HEMOPHLLIA                                                     |
| 1                                                              | 6.2.7.2  | Factor VII             | 1mg                     | 969       | 41,275.50 | 399.96                                                  |
| 2                                                              | 6.2.7.2  | Factor VIII PD         | 250 IU                  | 19,091    | 1,522.50  | 290.66                                                  |
| 3                                                              | 6.2.7.2  | Factor VIII PD         | 500 IU                  | 10,400    | 2,740.50  | 285.01                                                  |
| 4                                                              | 6.2.7.2  | Factor VIII with VWF   | 250 IU                  | 1,448     | 1,680.00  | 24.33                                                   |
| 5                                                              | 6.2.7.2  |                        | Factor VIII Recombinant | 250 IU    | 23,087    | 1,819.13                                                | 419.98            |
| 6                                                              | 6.2.7.2  |                        | Factor VIII Recombinant | 500 IU    | 11,603    | 3,274.46                                                | 379.93            |
| 7                                                              | 6.2.7.2  | Factor IX PD           | 600 IU                  | 4,826     | 5,594.40  | 269.99                                                  |
| 8                                                              | 6.2.7.2  | Factor IX Recombinant  | 500 IU                  | 1,469     | 12,250.00 | 179.95                                                  |
| 9                                                              | 6.2.7.2  | APCC/FEIBA             | 500 IU                  | 1,747     | 28612.50  | 499.86                                                  |
| Sub Total (II)..                                               | 2749.67  |
| Leucodepletion Bags                                            |
| 1                                                              | 6.2.7.2  | Leucodepletion Bags... | 44,313                  | 677.00    | 300.00    |
| Total (III)..                                                  | 300.00   |
| Grand Total (I + II + III) = 200.00 + 2749.67 + 300.00         | 3249.67  |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Purchase of drugs and pharmaceuticals as shown in the table (A), (B) and (C) above
The details of grant of administrative approval are as follows:
(a) Rs. 70.90 lakhs (Rupees Seventy Lakhs Ninety Thousand) under FMR Code" 6.1.1.9.1"
only).
(b) Rs. 993.30 lakhs (Rupees Nine Crores Three Lakhs Thirty Three Lakhs) under the head FMR Code" 6.2.7.1"
only a few thousand)
(c) Rs. 3249.67 Lakhs (Rupees Thirty Two Crores) under the head FMR Code" 6.2.7.2"
Nineteen fifty nine lacs sixty six thousand only) {(Rs. 200.00 lacs+ Rs. 300.00 lacs+ Rs. 2749.67
Target 3249.67 Lakhs)}
Page 3 of 6
# Page 4
Government Resolution No: PRASHAMA-1222/ PR No. 09/ HEALTH-7
The grants referred to in (a), (b) and (c) are being granted administrative approval subject to the following terms and conditions:
Terms and Conditions:
(1) The procurement process should be carried out only after ascertaining the requirement/ demand for the purchase of medicines and medicinal materials for the Arogyavardhini Kendra as per the directions of the Central Government from the funds available in the Project Implementation Plan 2021-22 under the National Urban Health Mission.
(2) May for the purchase of medicines and medicinal materials for the Arogyavardhini Kendra. Haffkine Bio Pharmaceuticals Corporation Ltd. The tender process should be carried out at the level of Parel and Mumbai.
(3) After verifying that the specifications of the said drugs and drug materials are as per the requirement and up-to-date, the technical specifications of the items to be procured should be as per the specifications agreed by the concerned experts/ technical committee/ officer.
(4) The technical specification of the items to be procured shall be such as to ensure that the procurement process is not carried out in a manner which will benefit the particular company. Also, the responsibility of sending the requisition as per the technical specifications of the items approved in the ROP will be of the respective head of the function. As the case may be, only the items included in the proposal should be purchased.
(5) The prescribed procurement procedure should be carried out in accordance with the provisions of the revised rule book of procedures for office procurement to be carried out by government departments published under the Government Decision, Industry, Energy and Labor Department, No: Bhankas-2014/ PR No. 82/ Part-III/ Industry-4, dated December 1, 2016.
(6) While giving administrative approval, it shall be ensured that the rates of the proposed procurement are lower than the market price and not higher than the rates at which the concerned supplier has supplied elsewhere.
(7) Pre/ post dispatch random sample inspection of the items to be purchased should be done to ensure that only the items with proper and correct specifications are purchased.
Page 4 of 6
# Page 5
Government Resolution No: PRASHAMA-1222/ PR No. 09/ HEALTH-7
(8) Storage and distribution of the items to be purchased after supply, supply chain management and inventory management should be done in a proper manner to ensure that these items do not remain unused and are used in a timely manner.
(9) The expenditure for the said procurement process shall be for the purchase of equipment, materials, kits and medicines required for effective decontamination and achievement of targets of the Hematology, Sickle Cell and Blood Storage Centres (BSUCs) under State Blood Cells in the Project Implementation Plans as approved by the Central Government for the year 2021-22.
(10) Also, it should be ensured that there is no duplication of the items to be purchased while carrying out the procurement process.
(11) The guidelines of the project plan under the National Urban Health Mission of the Central Government should be strictly followed while implementing the procurement process.
30/ Part- 2/2013/ Regulations, dated 17th April, 2015 in Annexure A to Rule No. 4 Rule No. 7 of Financial Powers Rules, 1978, Part-I, Sub-Section-II, the conditions mentioned in column No. 6 are to be fulfilled.
(13) After completion of the process, supply orders shall be issued only after approval of the Purchase Committee. Further, action in the matter should be taken in accordance with the provisions of the Government Resolution, Public Health Department, No: Purchase 2016/ PR No. 240/ Health-8, dated 26th July, 2017.
The Commissioner, Health Services and Mission Director, National Health Mission, Mumbai and Joint Director, Health Services (Procurement Cell), Mumbai shall be solely responsible for ensuring that the conditions and conditions mentioned in the aforesaid section (1) to (13) are fulfilled and the subject matter procurement is as per the rules and requirements.
30/13/ Regulations (Part-II), dated 17th April, 2015 under Rule No. 7 of the Financial Powers Rules, 1978 Part-I, Sub-Division-II, No. 4, is being issued under the powers conferred on the Administrative Departments to approve the purchase of implements, retail equipment and activity kits.
Page 6 of 5
# Page 6
Government Resolution No: PRASHAMA-1222/ PR No. 09/ HEALTH-7